Local and general anesthetics immediate hypersensitivity reactions

Immunology and Allergy Clinics of North America

Volumn 34, Issue 3, 2014, Pages 525-546

  Volcheck, Gerald W ^a   Mertes, Paul Michel ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Allergy; Anaphylaxis; Anesthetics; Perioperative; Skin tests

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; APROTININ; CHLORHEXIDINE; DYE; HISTAMINE; HYPNOTIC AGENT; IMMUNOGLOBULIN E; LATEX; LOCAL ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; OPIATE DERIVATIVE; TRYPTASE;

ANAPHYLAXIS; ANTIBODY SPECIFICITY; BASOPHIL ACTIVATION TEST; BLEEDING; CLINICAL FEATURE; CLINICAL STUDY; COLLOID; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; GENERAL ANESTHESIA; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOLOGICAL PROCEDURES; IN VITRO SPECIFIC IMMUNOGLOBULIN E TESTING; INCIDENCE; INTRACUTANEOUS TEST; INTRAOPERATIVE PERIOD; LOCAL ANESTHESIA; MORBIDITY; MORTALITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SAMPLE SIZE; SKIN TEST; SYMPTOM; CLASSIFICATION; HYPERSENSITIVITY, IMMEDIATE;

ANAPHYLAXIS; ANESTHETICS, GENERAL; ANESTHETICS, LOCAL; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, IMMEDIATE;

EID: 84904088555     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.03.004     Document Type: Review

References (119)

1. Mertes P.M., Demoly P., Malinovsky J.M. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol 2012, 12(4):361-368.
2. Fisher M.M., Doig G.S. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 2004, 27(6):393-410.
3. Malinovsky J.M., Decagny S., Wessel F., et al. Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients. Acta Anaesthesiol Scand 2008, 52(2):175-181.
4. Mertes P.M., Alla F., Trechot P., et al. Anaphylaxis during anesthesia in France: an 8-year national survey. JAllergy Clin Immunol 2011, 128(2):366-373.
5. Kroigaard M., Garvey L.H., Menne T., et al. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing?. Br J Anaesth 2005, 95(4):468-471.
6. Mancardi D.A., Albanesi M., Jonsson F., et al. The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 2013, 121(9):1563-1573.
7. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. JAllergy Clin Immunol 2004, 113(5):832-836.
8. Mertes P.M., Tajima K., Regnier-Kimmoun M.A., et al. Perioperative anaphylaxis. Med Clin North Am 2010, 94(4):761-789. xi.
9. Gurrieri C., Weingarten T.N., Martin D.P., et al. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg 2011, 113(5):1202-1212.
10. Lobera T., Audicana M.T., Pozo M.D., et al. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain. JInvestig Allergol Clin Immunol 2008, 18(5):350-356.
11. Dong S.W., Mertes P.M., Petitpain N., et al. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012, 78(8):868-878.
12. Harboe T., Guttormsen A.B., Irgens A., et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005, 102(5):897-903.
13. Fisher M., Baldo B.A. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 1994, 11(4):263-284.
14. Chong Y.Y., Caballero M.R., Lukawska J., et al. Anaphylaxis during general anaesthesia: one-year survey from a British allergy clinic. Singapore Med J 2008, 49(6):483-487.
15. Thienthong S., Hintong T., Pulnitiporn A. The Thai Anesthesia Incidents Study (THAI Study) of perioperative allergic reactions. JMed Assoc Thai 2005, 88(Suppl 7):S128-S133.
16. Pepys J., Pepys E.O., Baldo B.A., et al. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthesia 1994, 49(6):470-475.
17. Garvey L.H., Roed-Petersen J., Menne T., et al. Danish Anaesthesia Allergy Centre- preliminary results. Acta Anaesthesiol Scand 2001, 45(10):1204-1209.
18. Mitsuhata H., Matsumoto S., Hasegawa J. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 1992, 41:1664-1669.
19. Hepner D.L., Castells M.C. Anaphylaxis during the perioperative period. Anesth Analg 2003, 97(5):1381-1395.
20. Light K.P., Lovell A.T., Butt H., et al. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?. Pharmacoepidemiol Drug Saf 2006, 15(3):151-160.
21. Gibbs N.M., Sadleir P.H., Clarke R.C., et al. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013, 111(4):589-593.
22. Mertes P.M., Laxenaire M.C., Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003, 99(3):536-545.
23. Fisher M.M., Ramakrishnan N., Doig G., et al. The investigation of bronchospasm during induction of anaesthesia. Acta Anaesthesiol Scand 2009, 53(8):1006-1011.
24. Mertes P.M., Malinovsky J.M., Jouffroy L., et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. JInvestig Allergol Clin Immunol 2011, 21(6):442-453.
25. Mertes P.M., Bazin A., Alla F., et al. Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency. JInvestig Allergol Clin Immunol 2011, 21(3):171-178.
26. Mertes P.M., Malinovsky J.M., Mouton-Faivre C., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. JAllergy Clin Immunol 2008, 122(2):348-352.
27. Hunting A.S., Nopp A., Johansson S.G., et al. Anaphylaxis to patent blue V. I. Clinical aspects. Allergy 2010, 65(1):117-123.
28. Garvey L.H., Kroigaard M., Poulsen L.K., et al. IgE-mediated allergy to chlorhexidine. JAllergy Clin Immunol 2007, 120(2):409-415.
29. Laxenaire M.C., Mouton C., Frederic A., et al. Anaphylactic shock after tourniquet removal in orthopedic surgery. Ann Fr Anesth Reanim 1996, 15(2):179-184.
30. Nel L., Eren E. Peri-operative anaphylaxis. Br J Clin Pharmacol 2011, 71(5):647-658.
31. Kounis N.G., Mazarakis A., Tsigkas G., et al. Kounis syndrome: a new twist on an old disease. Future Cardiol 2011, 7(6):805-824.
32. Berroa F., Lafuente A., Javaloyes G., et al. The usefulness of plasma histamine and different tryptase cut-off points in the diagnosis of peranaesthetic hypersensitivity reactions. Clin Exp Allergy 2014, 44(2):270-277.
33. Enrique E., Garcia-Ortega P., Sotorra O., et al. Usefulness of UniCAP-tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy 1999, 54(6):602-606.
34. Mayer D.E., Krauskopf A., Hemmer W., et al. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int 2011, 212(1-3):96-101.
35. Brockow K., Garvey L.H., Aberer W., et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013, 68(6):702-712.
36. Lafuente A., Javaloyes G., Berroa F., et al. Early skin testing is effective for diagnosis of hypersensitivity reactions occurring during anesthesia. Allergy 2013, 68(6):820-822.
37. Soetens F., Rose M., Fisher M. Timing of skin testing after a suspected anaphylactic reaction during anaesthesia. Acta Anaesthesiol Scand 2012, 56(8):1042-1046.
38. Mata E., Gueant J.L., Moneret-Vautrin D.A., et al. Clinical evaluation of invitro leukocyte histamine release in allergy to muscle relaxant drugs. Allergy 1992, 47(5):471-476.
39. Assem E. Leukotriene C4 release from blood cells invitro in patients with anaphylactoid reactions to neuromuscular blockers. Agents Actions 1993, 38:C242-C244.
40. Ebo D.G., Bridts C.H., Hagendorens M.M., et al. Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 2008, 74(4):201-210.
41. Leysen J., Bridts C.H., De Clerck L.S., et al. Allergy to rocuronium: from clinical suspicion to correct diagnosis. Allergy 2011, 66(8):1014-1019.
42. Scala E., Guerra E.C., Giani M., et al. Delayed allergic reaction to suxamethonium driven by oligoclonal Th1-skewed CD4+CCR4+IFN-gamma+ memory T cells. Int Arch Allergy Immunol 2006, 141(1):24-30.
43. Delgado J., Quiralte J., Castillo R., et al. Systemic contact dermatitis from suxamethonium. Contact Dermatitis 1996, 35(2):120-121.
44. Fisher M.M., Baldo B.A. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993, 12(2):97-104.
45. Florvaag E., Johansson S.G., Oman H., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005, 49(4):437-444.
46. de Weck A.L. Immunochemical particularities of anaphylactic reactions to compounds used in anesthesia. Ann Fr Anesth Reanim 1993, 12(2):126-130.
47. Baldo B.A., Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983, 306(5940):262-264.
48. Baldo B.A., Harle D.G. Drug allergenic determinants. Molecular approaches to the study of allergens monographs in allergy 1990, vol. 28:11-51. Karger, Basel (Switzerland).
49. Laxenaire M.C., Gastin I., Moneret-Vautrin D.A., et al. Cross-reactivity of rocuronium with other neuromuscular blocking agents. Eur J Anaesthesiol Suppl 1995, 11:55-64.
50. Moneret-Vautrin D.A., Gueant J.L., Kamel L., et al. Anaphylaxis to muscle relaxants: cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases. JAllergy Clin Immunol 1988, 82(5 Pt 1):745-752.
51. Leynadier F., Dry J. Anaphylaxis to muscle-relaxant drugs: study of cross-reactivity by skin tests. Int Arch Allergy Appl Immunol 1991, 94(1-4):349-353.
52. Fisher M.M. Anaphylaxis to muscle relaxants: cross sensitivity between relaxants. Anaesth Intensive Care 1980, 8(2):211-213.
53. Fisher M.M. Cisatracurium and atracurium as antigens. Anaesth Intensive Care 1999, 27(4):369-370.
54. Fisher M.M., Baldo B.A. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000, 28:167-170.
55. Sadleir P.H., Clarke R.C., Bunning D.L., et al. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 2013, 110(6):981-987.
56. Gueant J.L., Mata E., Masson C., et al. Non-specific cross-reactivity of hydrophobic serum IgE to hydrophobic drugs. Mol Immunol 1995, 32(4):259-266.
57. Gueant J.L., Mata E., Namour F., et al. Criteria of evaluation and of interpretation of Sepharose drug IgE-RIA to anaesthetic drugs. Allergy 1999, 54(Suppl 58):17-22.
58. Laxenaire M.C. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim 1999, 18(7):796-809.
59. Galletly D.C., Treuren B.C. Anaphylactoid reactions during anaesthesia. Seven years' experience of intradermal testing. Anaesthesia 1985, 40(4):329-333.
60. Mertes P.M., Laxenaire M.C. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004, 23(12):1133-1143. [in French].
61. Guttormsen A.B. Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001, 45(10):1189-1190.
62. Rose M., Fisher M. Rocuronium: high risk for anaphylaxis?. Br J Anaesth 2001, 86(5):678-682.
63. Watkins J. Incidence of UK reactions involving rocuronium may simply reflect market use. Br J Anaesth 2001, 87(3):522.
64. Bhananker S.M., O'Donnell J.T., Salemi J.R., et al. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg 2005, 101(3):819-822.
65. Mertes P.M., Laxenaire M.C. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 2004, 4(1):7-16.
66. Baldo B.A., Fisher M.M., Pham N.H. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 2009, 39(3):325-344.
67. Dong S., Acouetey D.S., Gueant-Rodriguez R.M., et al. Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers. Clin Exp Allergy 2013, 43(11):1256-1262.
68. Florvaag E., Johansson S.G. The pholcodine case. Cough medicines, IgE-sensitization, and anaphylaxis: a devious connection. World Allergy Organ J 2012, 5(7):73-78.
69. Florvaag E., Johansson S.G., Irgens A., et al. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011, 66(7):955-960.
70. Doenicke A.W., Czeslick E., Moss J., et al. Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg 1998, 87(2):434-438.
71. Doenicke A., Moss J., Lorenz W., et al. Are hypotension and rash after atracurium really caused by histamine release?. Anesth Analg 1994, 78(5):967-972.
72. Cannon J.E., Fahey M.R., Moss J., et al. Large doses of vecuronium and plasma histamine concentrations. Can J Anaesth 1988, 35(4):350-353.
73. Fisher M. Anaphylaxis to anaesthetic drugs. Novartis Found Symp 2004, 257:193-202. [discussion: 202-10, 276-85].
74. Jooste E., Zhang Y., Emala C.W. Rapacuronium preferentially antagonizes the function of M2 versus M3 muscarinic receptors in guinea pig airway smooth muscle. Anesthesiology 2005, 102(1):117-124.
75. Jooste E.H., Sharma A., Zhang Y., et al. Rapacuronium augments acetylcholine-induced bronchoconstriction via positive allosteric interactions at the M3 muscarinic receptor. Anesthesiology 2005, 103(6):1195-1203.
76. Jooste E., Klafter F., Hirshman C.A., et al. Amechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 2003, 98(4):906-911.
77. McKinnon R.P., Wildsmith J.A. Histaminoid reactions in anaesthesia. Br J Anaesth 1995, 74(2):217-228.
78. Mertes P.M., Laxenaire M. Anaphylaxis during general anaesthesia. Prevention and management. CNS Drugs 2000, 14(2):115-133.
79. Mertes P.M., Laxenaire M.C. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 2004, 70(5):285-291.
80. Mertes P.M., Laxenaire M.C., Lienhart A., et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. JInvestig Allergol Clin Immunol 2005, 15(2):91-101.
81. Moneret-Vautrin D.A., Kanny G. Anaphylaxis to muscle relaxants: rational for skin tests. Allerg Immunol (Paris) 2002, 34(7):233-240.
82. Ebo D.G., Fisher M.M., Hagendorens M.M., et al. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007, 62(5):471-487.
83. Fisher M.M., Merefield D., Baldo B. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 1999, 82(5):770-773.
84. Thacker M.A., Davis F.M. Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant. Anaesth Intensive Care 1999, 27(2):190-193.
85. Gueant J.L., Mata E., Monin B., et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991, 46(6):452-458.
86. Guilloux L., Ricard-Blum S., Ville G., et al. Anew radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. JAllergy Clin Immunol 1992, 90(2):153-159.
87. Laroche D., Chollet-Martin S., Leturgie P., et al. Evaluation of a new routine diagnostic test for immunoglobulin e sensitization to neuromuscular blocking agents. Anesthesiology 2011, 114(1):91-97.
88. Ebo D.G., Venemalm L., Bridts C.H., et al. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. Anesthesiology 2007, 107(2):253-259.
89. Laroche D., Lefrancois C., Gerard J.L., et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 1992, 69(6):611-614.
90. Guttormsen A.B., Johansson S.G., Oman H., et al. No consumption of IgE antibody in serum during allergic drug anaphylaxis. Allergy 2007, 62(11):1326-1330.
91. Porri F., Lemiere C., Birnbaum J., et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999, 29(1):72-75.
92. Moscicki R.A., Sockin S.M., Corsello B.F., et al. Anaphylaxis during induction of general anesthesia: subsequent evaluation and management. JAllergy Clin Immunol 1990, 86(3 Pt 1):325-332.
93. Clarke R.S. Epidemiology of adverse reactions in anaesthesia in the United Kingdom. Klin Wochenschr 1982, 60(17):1003-1005.
94. Harle D., Baldo B., Fisher M. The molecular basis of IgE antibody binding to thiopentone. Binding of IgE from thiopentone-allergic and non-allergic subjects. Mol Immunol 1990, 27:853-858.
95. Fisher M., Ross J., Harle D., et al. Anaphylaxis to thiopentone: an unusual outbreak in a single hospital. Anaesth Intensive Care 1989, 17(3):361-365.
96. Murphy A., Campbell D.E., Baines D., et al. Allergic reactions to propofol in egg-allergic children. Anesth Analg 2011, 113(1):140-144.
97. Harle D.G., Baldo B.A., Coroneos N.J., et al. Anaphylaxis following administration of papaveretum. Case report: implication of IgE antibodies that react with morphine and codeine, and identification of an allergic determinant. Anesthesiology 1989, 71:489-494.
98. Warshaw E.M., Schram S.E., Belsito D.V., et al. Patch-test reactions to topical anesthetics: retrospective analysis of cross-sectional data 2001 to 2004. Dermatitis 2008, 19:81-85.
99. Giovannitti J.A., Bennett C.R. Assessment of allergy to local anesthetics. JAm Dent Assoc 1979, 98:701-706.
100. Schatz M., Fung D.L. Anaphylactic and anaphylactoid reactions due to anesthetic agents. Clin Rev Allergy 1986, 4:215-227.
101. Bhole M.V., Manson A.L., Seneviratne S.L., et al. IgE-mediated allergy to local anaesthetics: separating fact from perception: a UK perspective. Br J Anaesth 2012, 108(6):903-911.
102. Oertel R., Ebert U., Rahn R., et al. Clinical pharmacokinetics of articaine. Clin Pharmacokinet 1997, 33(6):417-425.
103. Ogle O.E., Mahjoubi G. Local anesthesia: agents, techniques and complications. Dent Clin North Am 2012, 56:133-148.
104. Harboe T., Guttormsen A.B., Aarebrot S., et al. Suspected allergy to local anesthetics: follow-up in 135 cases. Acta Anaesthesiol Scand 2010, 54:536-542.
105. Gall H., Kaufmann R., Kalveram C.M. Adverse reactions to local anesthetics: analysis of 197 cases. JAllergy Clin Immunol 1996, 97:933-937.
106. Berkun Y., Ben-Zvi A., Levy Y., et al. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol 2003, 91:342-345.
107. McClimon B., Rank M., Li J. The predictive value of skin testing in the diagnosis of local anesthetic allergy. Allergy Asthma Proc 2011, 32:95-98.
108. Wasserfallen J.B., Frei P.C. Long-term evaluation of usefulness of skin and incremental challenge tests in patients with history of adverse reaction to local anesthetics. Allergy 1995, 50:162-165.
109. Gonzalez-Delgado P., Anton R., Soriano V., et al. Cross-reactivity among amide-type local anesthetics in a case of allergy to mepivacaine. JInvestig Allergol Clin Immunol 2006, 16(5):311-313.
110. Noormalin A., Shajnaz M., Rosmilah M., et al. IgE-mediated hypersensitivity to lignocaine; a case report. Trop Biomed 2005, 22:179-183.
111. Venemalm L., Degerbecck F., Smith W. IgE-mediated reaction to mepivacaine. JAllergy Clin Immunol 2008, 121:1058-1059.
112. Stahl M., Gome R., Waibel K. Allergy to local anesthetics: specific IgE demonstration to both amides and esters in a single patient. Ann Allergy Asthma Immunol 2012, 108:60-67.
113. Macy E., Schatz M., Zeiger R.S. Immediate hypersensitivity to methylparaben causing false-positive results of local anesthetic skin testing or provocative dose testing. Permanente J 2002, 6:17-21.
114. Macy E. Local anesthetic adverse reaction evaluations: the role of the allergist. Ann Allergy Asthma Immunol 2003, 91:319-320.
115. Gonzalez-Estrada A., Pien L.C., Lang D.M. Perioperative anaphylaxis: antibiotics are the most common identifiable cause. Ann Allergy Asthma Immunol 2013, 111(5 Suppl 1):A3.
116. Sanz M.L., Gamboa P.M., Mayorga C. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 2009, 9:298-304.
117. Aalto-Korte K., Makinen-Kiljunen S. Symptoms of immediate chlorhexidine hypersensitivity in patients with a positive prick test. Contact Dermatitis 2006, 55:173-177.
118. Laxenaire M.C., Charpenteir C., Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 1994, 13:301-310.
119. Oswald A.M., Joly L.M., Gury C., et al. Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology 2003, 99:762-763.